KARLA LOPEZ: Open Payments
NPI 1578082939 · FONTANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$848 in 53 payments from 9 companies in 2025. Trend: 2023 $909 · 2024 $1,059 · 2025 $848
Food & beverage: $848
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $534 |
| Novo Nordisk Inc | 4 | $68 |
| Lilly USA, LLC | 2 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| Gilead Sciences, Inc. | 2 | $46 |
| Exact Sciences Corporation | 2 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: RINVOQ, CREON, LINZESS, SKYRIZI, Kerendia, Wegovy, MOUNJARO, KISUNLA.
Industry payments across CA — which companies pay providers there.
